Wells Fargo’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.68M Sell
42,368
-28,270
-40% -$1.79M ﹤0.01% 2691
2025
Q1
$3.74M Buy
70,638
+33,314
+89% +$1.76M ﹤0.01% 2345
2024
Q4
$2.09M Buy
37,324
+7,850
+27% +$439K ﹤0.01% 2776
2024
Q3
$1.54M Sell
29,474
-61
-0.2% -$3.2K ﹤0.01% 2933
2024
Q2
$1.21M Buy
29,535
+2,550
+9% +$105K ﹤0.01% 3069
2024
Q1
$1.17M Sell
26,985
-12,774
-32% -$553K ﹤0.01% 3038
2023
Q4
$1.83M Sell
39,759
-13,950
-26% -$641K ﹤0.01% 2702
2023
Q3
$1.23M Sell
53,709
-23,385
-30% -$536K ﹤0.01% 2948
2023
Q2
$1.27M Buy
77,094
+26,291
+52% +$434K ﹤0.01% 3111
2023
Q1
$906K Buy
50,803
+44,060
+653% +$786K ﹤0.01% 3224
2022
Q4
$196K Buy
6,743
+4,569
+210% +$133K ﹤0.01% 3916
2022
Q3
$54K Sell
2,174
-6,754
-76% -$168K ﹤0.01% 4619
2022
Q2
$37K Sell
8,928
-890
-9% -$3.69K ﹤0.01% 4888
2022
Q1
$113K Sell
9,818
-11,325
-54% -$130K ﹤0.01% 4947
2021
Q4
$210K Buy
21,143
+18,930
+855% +$188K ﹤0.01% 4873
2021
Q3
$29K Sell
2,213
-7,558
-77% -$99K ﹤0.01% 5521
2021
Q2
$191K Sell
9,771
-11,292
-54% -$221K ﹤0.01% 4751
2021
Q1
$448K Sell
21,063
-10,218
-33% -$217K ﹤0.01% 4444
2020
Q4
$930K Buy
31,281
+14,256
+84% +$424K ﹤0.01% 4019
2020
Q3
$369K Sell
17,025
-4,481
-21% -$97.1K ﹤0.01% 4443
2020
Q2
$480K Buy
21,506
+6,492
+43% +$145K ﹤0.01% 4237
2020
Q1
$229K Sell
15,014
-8,292
-36% -$126K ﹤0.01% 4442
2019
Q4
$535K Buy
23,306
+12,010
+106% +$276K ﹤0.01% 4213
2019
Q3
$244K Buy
11,296
+4,561
+68% +$98.5K ﹤0.01% 4676
2019
Q2
$148K Sell
6,735
-1,527
-18% -$33.6K ﹤0.01% 4926
2019
Q1
$226K Buy
8,262
+626
+8% +$17.1K ﹤0.01% 4688
2018
Q4
$205K Buy
7,636
+2,047
+37% +$55K ﹤0.01% 4701
2018
Q3
$163K Buy
5,589
+789
+16% +$23K ﹤0.01% 4919
2018
Q2
$150K Buy
4,800
+199
+4% +$6.22K ﹤0.01% 4975
2018
Q1
$92K Buy
4,601
+86
+2% +$1.72K ﹤0.01% 5097
2017
Q4
$131K Buy
+4,515
New +$131K ﹤0.01% 4981